Back to top

Image: Bigstock

New Strong Buy Stocks for June 7th

Read MoreHide Full Article

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

At Home Group Inc. (HOME - Free Report) : This owner and operator of home-decorating accessories stores has seen the Zacks Consensus Estimate for its current year earnings increasing 11.8% over the last 60 days.

At Home Group Inc. Price and Consensus

Energy Transfer LP (ET - Free Report) : This owner and operator of a diversified portfolio of energy assets primarily in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Energy Transfer LP Price and Consensus

Oshkosh Corporation (OSK - Free Report) : This manufacturer and marketer of access equipment, specialty vehicles and truck bodies has seen the Zacks Consensus Estimate for its current year earnings increasing 17.5% over the last 60 days.

Oshkosh Corporation Price and Consensus

Sportsman's Warehouse Holdings, Inc. (SPWH - Free Report) : This outdoor sporting goods retailer has seen the Zacks Consensus Estimate for its current year earnings increasing 62% over the last 60 days.

Sportsmans Warehouse Holdings, Inc. Price and Consensus

Lumber Liquidators Holdings, Inc. (LL - Free Report) : This multi-channel specialty retailer of hard-surface flooring, and hard-surface flooring enhancements and accessories has seen the Zacks Consensus Estimate for its current year earnings increasing 18.3% over the last 60 days.

Lumber Liquidators Holdings, Inc Price and Consensus

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>